Devices that are approved through a process that does not require any clinical evidence for FDA authorization should not ...

The immediate aftermath of the 2024 presidential election has brought renewed attention to regulatory policy at the U.S. Food ...

Medicare drug price negotiation could have significant impacts on investment in post-approval studies for cancer treatment ...

State employee health plans are consuming an ever-larger portion of state budgets because of rising health insurance premiums. Often the largest purchaser of commercial health insurance in their ...

Caremark, Express Scripts, and OptumRx continue to defend themselves against a Federal Trade Commission administrative ...

Rhea Boyd, MD, MPH, Pediatrician and Child and Public Health Advocate, interviews Andrew Winn from the Insight Garden Program about the relationship between the environment and people in incarcerated ...

Given the disproportionate impact of climate change on low-income communities of color, Medicaid has an important opportunity to meaningfully invest in communities by mitigating the health impacts of ...

Health Affairs announced today that Editor-in-Chief Alan Weil will leave his role at the end of the year.

Diagnosis-based payment systems can create incentives to upcode patients to a higher level of severity to increase payment. In some instances, upcoding can be a form of fraud if providers code ...

On September 26, 2024, the White House released an executive order allowing states to use Medicaid to reimburse health care ...

The December issue of Health Affairs contains many articles that examine how health care markets function. Topics covered include coding practices that affect risk adjustment, competition in the ...